CompoAtlas

Harpagophytum Reine des prés

Food supplement declared in France, declaration No 2019-10-380

Harpagophytum Reine des prés (Yves Ponroy) is a food supplement declared in France. Status: withdrawal from the market announced for 28 February 2027. Main ingredients: Harpagophytum procumbens 250 mg per day, Filipendula ulmaria 50 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Yves Ponroy
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Withdrawal from the market announced for 28 February 2027
Form
Capsule
Daily dose
1 gélule
Directions for use
à avaler avec un verre d'eau au cours du petit déjeuner
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Allergy to salicylate derivatives, Children (under 12), Young children (aged 1 to 3), Infants (under 1 year), Taking anticoagulants, Ulcer (stomach or duodenum)
Objectives stated by the manufacturer (these are not authorised claims)
Joints

Declaration 215046, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Harpagophytum procumbensRacineExtrait sec aqueux250 mg
Filipendula ulmaria (L.) Maxim.Parties aériennesExtrait sec aqueux50 mg

Additives

Hydroxypropyl Méthyl Cellulose, E460, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consulter votre médecin ou pharmacien en cas d'usage concomitant d'anticoagulants. Ne pas utiliser chez les enfants et adolescents de moins de 18 ans. Ne pas utiliser en cas d'ulcères gastrique ou duodénal ou de calculs biliaires. Déconseillé aux personnes souffrant d'allergie aux dérivés salicylés.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Yves Ponroy

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Harpagophytum Reine des prés (Yves Ponroy): composition and regulation”, https://compoatlas.com/en/supplements/products/215046-harpagophytum-reine-des-pres, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line